AbstractThe Dutch pharmaceutical industry is characterized by a high degree of innovative rivalry resulting in frequent rises and falls in market shares by both firms and products. Conventional concentration ratios, Herfindahl indices and market share stability measures are not highly correlated. The market, however, does display price sensitivity. Elasticity of demand for new products is inversely related to their incremental quality and directly related to their age.